PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Something from nothing: Physicists model vacuum tunnelling in a 2D superfluid

2025-09-01
(Press-News.org) In 1951, physicist Julian Schwinger theorized that by applying a uniform electrical field to a vacuum, electron-positron pairs would be spontaneously created out of nothing, through a phenomenon called quantum tunnelling.

The problem with turning the matter-out-of-nowhere theory into Star Trek replicators or transporters? Enormously high electric fields would be required—far beyond the limits of any direct physical experiments. 

As a result, the aptly named Schwinger effect has never been seen. 

Now theoretical physicists at the University of British Columbia (UBC) have described a parallel effect in a more manageable system. In their model, they substitute a thin film of superfluid helium for the vacuum, and the background flow of the superfluid for the massive electrical field.

“Superfluid Helium-4 is a wonder. At a few atomic layers thick it can be cooled very easily to a temperature where it's basically in a frictionless vacuum state,” explains Dr. Philip Stamp, a theorist at UBC working on condensed matter and quantum gravity, and author of the new findings published today in PNAS. 

“When we make that frictionless vacuum flow, instead of electron-positron pairs appearing, vortex/anti-vortex pairs will appear spontaneously, spinning in opposite directions to one another.”

In the paper, Dr. Stamp and UBC colleague Michael Desrochers outline the theory and the mathematics behind it—mapping out a detailed approach to conducting a direct experiment. 

Vacuum tunneling is a process of keen interest in quantum mechanics and quantum field theory. In quantum theory, vacuums aren’t empty, they’re filled with fluctuating fields that can lead to the temporary appearance and disappearance of virtual particles. 

“We believe the Helium-4 film provides a nice analog to several cosmic phenomena,” adds Dr. Stamp. “The vacuum in deep space, quantum black holes, even the very beginning of the Universe itself. And these are phenomena we can’t ever approach in any direct experimental way.” 

However, Dr. Stamp emphasizes that the real interest of the work may lie less in an analogs – which always have limitations – and more in the way it alters our understanding of superfluids, and of phase transitions in two-dimensional systems. 

“These are real physical systems in their own right, not analogs. And we can do experiments on these.”

At the mathematical level, the researchers needed several breakthroughs to make the theory work. For example, previous researchers looking at vortices in superfluids have treated the vortex mass as an unchanging constant. Dr. Stamp and Desrochers showed that this mass will vary dramatically as the vortices move, fundamentally changing our understanding of vortices in both fluids and the early universe. 

"It’s exciting to understand how and why the mass varies, and how this affects our understanding of quantum tunnelling processes, which are ubiquitous in physics, chemistry and biology," says Desrochers.

Stamp also argues that the same mass variability will occur with electron-positron pairs in the Schwinger effect, thence modifying Schwinger’s theory, in a kind of ‘revenge of the analog’.

The work was supported by the National Science and Engineering Research Council.

END


ELSE PRESS RELEASES FROM THIS DATE:

CRISPR’s efficiency triples with DNA-wrapped nanoparticles

2025-09-01
With the power to rewrite the genetic code underlying countless diseases, CRISPR holds immense promise to revolutionize medicine. But until scientists can deliver its gene-editing machinery safely and efficiently into relevant cells and tissues, that promise will remain out of reach. Now, Northwestern University chemists have unveiled a new type of nanostructure that dramatically improves CRISPR delivery and potentially extends its scope of utility. Called lipid nanoparticle spherical nucleic acids (LNP-SNAs), these tiny structures carry the full set of CRISPR editing tools — Cas9 enzymes, ...

For the first time in 40 Years, Panama’s deep and cold ocean waters failed to emerge, possibly affecting fisheries and coral health

2025-09-01
During the dry season in Central America (generally between December and April), northern trade winds generate upwelling events in the ocean waters of the Gulf of Panama. Upwelling is a process that allows cold, nutrient-rich waters from the depths of the ocean to rise to the surface. This dynamic supports highly productive fisheries and helps protect coral reefs from thermal stress. Thanks to this movement of water, the sea along Panama’s Pacific beaches remains cooler during the "summer" vacation season. Scientists from the Smithsonian Tropical Research Institute (STRI) have studied this phenomenon and their records show that this seasonal upwelling, ...

Depression may make learning to avoid unpleasant events harder

2025-09-01
Depression alters how people pursue rewards, but, conversely, whether depressive symptoms influence how people learn to avoid nonrewarding, unpleasant events is less clear. Ryan Tomm and colleagues, from the University of British Colombia, addressed this question in their eNeuro paper to shed more light on the relationship between depression and learning. This work brought together researchers from preclinical, cognitive, and clinical backgrounds, building stronger connections across fields to better understand the mechanisms of depression.    The researchers developed a behavioral task for study volunteers based off rodent research ...

Study sheds light on how pediatric brain tumors grow

2025-09-01
The most common type of brain tumor in children, pilocytic astrocytoma (PA), accounts for about 15% of all pediatric brain tumors. Although this type of tumor is usually not life-threatening, the unchecked growth of tumor cells can disrupt normal brain development and function. Current treatments focus mainly on removing the tumor cells, but recent studies have shown that non-cancerous cells, such as nerve cells, also play a role in brain tumor formation and growth, suggesting novel approaches to treating these cancers. Scientists have long known that a nerve cell signaling chemical called glutamate can increase growth of cancers throughout the body, but despite ...

Rare seasonal brain shrinkage in shrews is driven by water loss, not cell death

2025-09-01
Common shrews are one of only a handful of mammals known to flexibly shrink and regrow their brains. This rare seasonal cycle, known as Dehnel’s phenomenon, has puzzled scientists for decades. How can a brain lose volume and regrow months later without sustaining permanent damage? A study using non-invasive MRI has scanned the brains of shrews undergoing shrinkage, identifying a key molecule involved in the phenomenon: water. “Our shrews lost nine percent of their brains during shrinkage, but the cells did not die,” says first author Dr. Cecilia Baldoni, a postdoctoral researcher from the Max Planck Institute of Animal Behavior ...

AI co-pilot boosts noninvasive brain-computer interface by interpreting user intent

2025-09-01
UCLA engineers have developed a wearable, noninvasive brain-computer interface system that utilizes artificial intelligence as a co-pilot to help infer user intent and complete tasks by moving a robotic arm or a computer cursor. Published in Nature Machine Intelligence, the study shows that the interface demonstrates a new level of performance in noninvasive brain-computer interface, or BCI, systems. This could lead to a range of technologies to help people with limited physical capabilities, such as those with paralysis or neurological conditions, handle and move objects more easily and precisely. The team developed custom algorithms to decode electroencephalography, or EEG — ...

Black adults face heart failure nearly 14 years earlier than white patients

2025-09-01
Black adults first hospitalized for heart failure in the U.S. at age 60.1, vs. 73.6 for white adults Hispanic patients first hospitalized at 65.4; Asian American patients at 70.6 CHICAGO --- Black adults in the U.S. are first hospitalized for heart failure nearly 14 years earlier than white adults, reports a Northwestern Medicine study that analyzed data from more than 42,000 patients across hundreds of hospitals nationwide. The study also found that Hispanic patients were hospitalized about eight years earlier than white patients, and Asian patients about three years earlier. On average, white patients were first hospitalized ...

Study detects multidrug-resistant KPC-producing bacteria in Chilean wastewater for the first time

2025-09-01
A team of Chilean researchers has identified, for the first time in the country, the presence of KPC-type carbapenemase-producing bacteria in wastewater samples from the Greater Concepción Metropolitan Area. The finding, published in the journal Biological Research, raises concerns about the environmental circulation of microorganisms with high levels of resistance to critical clinically used antibiotics and reinforces the need for surveillance within the framework of "One Health." The research, which was part of Franco Ilabaca's Master's thesis in Microbiology, was led by Dr. ...

New artificial intelligence model accurately identifies which atrial fibrillation patients need blood thinners to prevent stroke

2025-09-01
Conference: “Late Breaking Science” presentation at the European Society of Cardiology - AI driven cardiovascular biomarkers and clinical decisions Title: Graph Neural Network Automation of Anticoagulation Decision-Making Date: Embargo lifts Monday, September 1, 4:00 pm EDT Bottom Line: Mount Sinai researchers developed an AI model to make individualized treatment recommendations for atrial fibrillation (AF) patients—helping clinicians accurately decide whether or not to treat them with anticoagulants (blood thinner medications) to prevent stroke, which is currently the standard treatment course in this patient population. This model presents a completely ...

Safety of factor XI inhibition with abelacimab in atrial fibrillation by kidney function

2025-09-01
About The Study: In this secondary analysis of the AZALEA-TIMI 71 randomized clinical trial, abelacimab consistently reduced the risk of bleeding relative to rivaroxaban irrespective of kidney function. These findings suggest that abelacimab may offer a particularly favorable safety profile among those with chronic kidney disease; however, larger studies are necessary to characterize the efficacy of abelacimab for stroke prevention in atrial fibrillation. Corresponding Author: To contact the corresponding author, Siddharth M. Patel, MD, MPH, email spatel@bwh.harvard.edu.  To access the embargoed study: Visit our For ...

LAST 30 PRESS RELEASES:

Personalized risk messages fail to boost colorectal cancer screening participation

Something from nothing: Physicists model vacuum tunnelling in a 2D superfluid

CRISPR’s efficiency triples with DNA-wrapped nanoparticles

For the first time in 40 Years, Panama’s deep and cold ocean waters failed to emerge, possibly affecting fisheries and coral health

Depression may make learning to avoid unpleasant events harder

Study sheds light on how pediatric brain tumors grow

Rare seasonal brain shrinkage in shrews is driven by water loss, not cell death

AI co-pilot boosts noninvasive brain-computer interface by interpreting user intent

Black adults face heart failure nearly 14 years earlier than white patients

Study detects multidrug-resistant KPC-producing bacteria in Chilean wastewater for the first time

New artificial intelligence model accurately identifies which atrial fibrillation patients need blood thinners to prevent stroke

Safety of factor XI inhibition with abelacimab in atrial fibrillation by kidney function

Combination of mini-camera and AI predicts recurrent heart attack

Study Reveals Details of Overactive Immune System in Patients with Chronic Fatigue Syndrome (ME/CFS)

UTSA and UT Health San Antonio complete merger to become The University of Texas at San Antonio

Helicobacter pylori screening after acute myocardial infarction

Solar Orbiter traces superfast electrons back to Sun

GaN-based electron beam technology from Nagoya University startup poised to overcome critical semiconductor manufacturing challenges at KIOXIA

Circle versus rectangle: Finding ‘Earth 2.0’ may be easier using a new telescope shape

Metformin changes blood metal levels in humans

Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation

Fractional flow reserve–guided complete vs culprit-only revascularization in non–ST-elevation myocardial infarction and multivessel disease

Participation of women in cardiovascular trials from 2017 to 2023

Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction

Changes in biology of internal fat may be the leading cause of heart failure

Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk

Promising new drug for people with stubborn high blood pressure

One shot of RSV vaccine effective against hospitalization in older adults for two seasons

Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults

Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis

[Press-News.org] Something from nothing: Physicists model vacuum tunnelling in a 2D superfluid